POAI
Predictive Oncology Inc. (POAI)
Last Price$1.3(9.4%)
Market Cap$8,155.2K
Last Earnings date
Sep'24
Q3 2024
($0.48)
50.0% miss
Next quarter EPS Estimate
($0.25)
(70.6%)YoY

POAI Earnings and Expectations

Revenue

Crunching data... Almost there!

POAI EPS (Earnings Per Share)

Crunching data... Almost there!

POAI Historical Revenue & EPS and Expectations

1Y
3Y
5Y
10Y
Revenue
EPS
$0.0$1,000.0K$2,000.0K$3,000.0K$4,000.0KJan'20Apr'20Jul'20Oct'20Jan'21Apr'21Jul'21Oct'21Jan'22Apr'22Jul'22Oct'22Jan'23Apr'23Jul'23Oct'23Jan'24Apr'24Jul'24$347.5K$182.8K$293.8K$350.2K$476.5K$371.6K$363.5K$490.1K$335.0K$278.7K
Value Sense
Actual Revenue
Forecast Revenue

POAI Earnings History

Dec'14Mar'15Jun'15Sep'15Dec'15Mar'16Jun'16Sep'16Dec'16Mar'17Jun'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24
Revenue actual$165.8K$151.3K$234.0K$85.8K$183.3K$96.9K$85.4K$134.6K$139.6K$175.2K$106.8K$152.5K$220.3K$411.6K$358.6K$329.9K$311.5K$255.2K$286.2K$522.7K$347.5K$294.9K$182.8K$480.8K$293.8K$280.3K$350.2K$313.7K$476.5K$314.6K$371.6K$455.8K$363.5K$239.9K$490.1K$715.1K$335.0K$419.6K$278.7K$345.7K
Revenue estimateN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A$350.0K$350.0K$600.0K$600.0K$2,500.0K$1,000.0K$2,000.0K$4,000.0K$500.0K$500.0K$500.0K$500.0K$500.0K$500.0K$278.7K$500.0K
Revenue surprise0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%16.1%19.9%41.6%47.7%80.9%68.5%81.4%88.6%27.3%52.0%2.0%43.0%33.0%16.1%0.0%30.9%
EPS actual($190.76)($359.55)($1,790.52)($1,073.46)($31.26)($601.37)($190.06)($64.00)($1.14)($42.00)($82.48)($32.00)($2.52)($30.92)($40.00)($37.83)($2.19)($41.87)$9.80($25.48)($2.79)($18.61)($7.27)($8.46)($0.76)($2.20)($1.00)($1.66)($0.12)($1.01)($5.08)($1.02)($5.65)($1.07)($0.98)($0.78)($0.86)($1.04)($0.68)($0.48)
EPS estimateN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A($3.60)($1.80)($1.60)($1.00)($0.50)($0.80)($0.60)($0.20)($1.20)($1.20)($1.20)($1.20)($1.20)($1.20)$1.34($0.32)
EPS surprise0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%78.9%22.2%37.5%66.0%76.0%26.2%746.7%410.0%370.8%10.8%18.3%35.0%28.3%13.3%150.6%50.0%

Overview of financial statements

Income statement
Balance sheet
Cash Flow statement
$345.7K (51.7%) YoY
$148.8K (75.5%) YoY
43.0% margin
Cost of revenue
$196.9K 84.1% YoY
Operating expenses
$2,462.7K (34.5%) YoY
Net income
$3,094.7K (2.2%) YoY
(895.2%) margin
Other: $2,461.3K
SG&A
$1,829.3K (37.3%) YoY
529.2% of revenue

Competing with POAI Earnings

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Revenue
EPS
Last quarter Revenue growth
Last quarter EPS growth
Last quarter Revenue surpriseLast quarter EPS surprise
Next quarter Revenue growth
Next quarter EPS growth
Last 10 Earnings (how many miss vs beat)
1Y Fwd Revenue growth
1Y Fwd EPS growth
$8,155.2K
$1,379.1K
($3.06)
(51.7%)
(38.5%)
undefinedN/A
undefinedN/A
1.2%
(47.9%)
Beats: 0
Misses: 10
(21.7%)
(40.2%)
$207.3B
$8,352.1M
$8.46
25.2%
123.8%
Beat by 7.8%
Beat by 117.1%
(8.7%)
(53.6%)
Beats: 8
Misses: 2
14.2%
20.5%
$66.3B
$20.6B
$6.03
9.8%
8.2%
Beat by 1.2%
Miss by 64.8%
5.5%
228.9%
Beats: 8
Misses: 2
9.0%
145.1%
$46.6B
$9,926.1M
$1.48
0.9%
(100.0%)
Beat by 2.8%
Miss by 100.0%
1.1%
0.0%
Beats: 8
Misses: 2
2.8%
50.8%
$34.6B
$4,926.8M
$4.03
10.3%
N/A
Beat by 1.1%
Miss by 191.3%
1.3%
(213.5%)
Beats: 7
Misses: 3
9.2%
35.4%
$18.6B
$3,895.4M
$1.97
9.8%
34.9%
Beat by 2.1%
Miss by 36.3%
(3.9%)
57.8%
Beats: 6
Misses: 4
5.8%
102.2%
$17.9B
$12.9B
($1.28)
(29.1%)
N/A
Beat by 3.0%
Miss by 293.4%
(4.6%)
(150.5%)
Beats: 6
Misses: 4
148.7%
N/A
$16.9B
$2,893.1M
$6.74
2.3%
(3.8%)
Beat by 1.2%
Beat by 3.5%
(2.8%)
(6.1%)
Beats:
Misses:
5.3%
10.7%
$14.7B
$4,038.9M
$3.18
0.9%
(15.5%)
Beat by 4.5%
Miss by 14.1%
1.0%
19.0%
Beats: 8
Misses: 2
3.4%
27.1%
$10.4B
$2,094.4M
($5.68)
9.4%
N/A
Beat by 19.5%
Miss by 879.3%
(16.8%)
(115.8%)
Beats: 9
Misses: 1
1.9%
161.9%

FAQ

1. When was Predictive Oncology Inc.'s last earnings date?

Predictive Oncology Inc.'s last earnings date was Sep'24 (Q3 2024).

2. What is Predictive Oncology Inc.'s EPS, and was there a surprise?

3. What is Predictive Oncology Inc.'s revenue, and was there a surprise?

4. What is Predictive Oncology Inc.'s next quarter EPS estimate?

Predictive Oncology Inc.'s next quarter EPS estimate is ($0.25), with an expected (70.6%) YoY growth.